The Sixth CSCO-CAHON-SITC Joint Symposium in Immuno-Oncology
September 24, 2016
2:30 – 5:00 p.m.
International Conference Center Hotel • Xiamen, Fujian, China
International Multifunctional Hall 2, 2nd Floor
Presented by the Chinese Society of Clinical Oncology (CSCO) in collaboration with the Chinese American Hematologist and Oncologist Network (CAHON) and the Society for Immunotherapy of Cancer (SITC)
This joint workshop provided information about the mechanisms of action and the clinical application of immunotherapy treatment methods. The workshop was part of the 19th Annual Meeting of the the Chinese Society of Clinical Oncology, which was held on September 21-25, 2016. The theme of the conference this year was "Delicacy Management and Precision Treatment." The conference provided opportunities for worldwide communication and cooperation on clinical oncology. The goal was to advocate standardization of comprehensive treatment, encourage innovation in clinical research and promote the development of clinical oncology.
Lisa Butterfield, PhD – University of Pittsburgh, SITC
Jin Li, MD, PhD – Fudan University Cancer Hospital, CSCO
Zihai Li, MD, PhD – MUSC Hollings Cancer Center, CAHON, SITC
Session Speakers and Topics
||Cancer Immunotherapy With CAR T Cells
Zhun Zhu – Beijing Cancer Hospital, CSCO
||Adoptive T Cell Therapy for Solid Tumors – Ready for Prime Time?
Cassian Yee – MD Anderson Cancer Center, CAHON and SITC
||Primary and Adaptive Resistance to Immune Checkpoint Blockade
Peter Hammerman – Dana-Farber Institute, Broad Institute and Harvard Medical School
||Why the Immunology Ice Breaking Always Happens in Melanoma
Lu Si – Beijing Cancer Hospital,CSCO
||Clinical Applications of Bispecific Antibodies
Delong Liu – New York Medical College, CAHON
||Immunologic Impact of Tumor Antigens in Vaccines for Melanoma and Hepatocellular Cancer
Lisa Butterfield – University of Pittsburgh, SITC
For more information about the CSCO 19th Annual Meeting, click here.